References
- Kohler BA, Sherman RL, Howlader N, et al. Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst 2015;107:djv048
- Chen J, Jiang Y, Liu X, et al. Genetic variants at chromosome 9p21, 10p15 and 10q22 and breast cancer susceptibility in a Chinese population. Breast Cancer Res Treat 2012;132:741–6
- Bhatelia K, Singh K, Singh R. TLRs: linking inflammation and breast cancer. Cell Signal 2014;26:2350–7
- McNamara KM, Moore NL, Hickey TE, et al. Complexities of androgen receptor signalling in breast cancer. Endocr Relat Cancer 2014;21:T161–81
- Wang W, Nag SA, Zhang R. Targeting the NFκB signaling pathways for breast cancer prevention and therapy. Curr Med Chem 2015;22:264–89
- Mavaddat N, Pharoah PD, Michailidou K, et al. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst 2015;107:djv036
- Fletcher O, Dudbridge F. Candidate gene-environment interactions in breast cancer. BMC Med 2014;12:195
- Vachon CM, Pankratz VS, Scott CG, et al. The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst 2015;107:dju397
- Son BH, Kim MK, Yun YM, et al. Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women. J Cancer Res Clin Oncol 2015;141:633–45
- Key T, Appleby P, Barnes I, et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606–16
- Lipphardt MF, Deryal M, Ong MF, et al. ESR1 single nucleotide polymorphisms predict breast cancer susceptibility in the central European Caucasian population. Int J Clin Exp Med 2013;6:282–8
- Levesque E, Huang SP, Audet-Walsh E, et al. Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression. Clin Cancer Res 2013;19:699–709
- Thomas C, Gustafsson JA. Estrogen receptor mutations and functional consequences for breast cancer. Trends Endocrinol Metab 2015;26:467–76
- Parker MG, Cowley SM, Heery D, et al. Function of estrogen receptors in breast cancer. Breast Cancer 1997;4:204–8
- Toy W, Shen Y, Won H, et al. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet 2013;45:1439–45
- Li LW, Xu L. Menopausal status modifies breast cancer risk associated with ESR1 PvuII and XbaI polymorphisms in Asian women: a HuGE review and meta-analysis. Asian Pac J Cancer Prev 2012;13:5105–11
- Ritte R, Lukanova A, Tjonneland A, Olsen A, et al. Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study. Int J Cancer 2013;132:2619–29
- Li CI, Malone KE, Daling JR, et al. Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol 2008;167:230–9
- Baer HJ, Schnitt SJ, Connolly JL, et al. Early life factors and incidence of proliferative benign breast disease. Cancer Epidemiol Biomarkers Prev 2005;14:2889–97
- Ambrosone CB, Zirpoli G, Hong CC, et al. Important role of menarche in development of estrogen receptor-negative breast cancer in African American women. J Natl Cancer Inst 2015;107:djv172
- Rostami S, Kohan L, Mohammadianpanah M. The LEP G-2548A gene polymorphism is associated with age at menarche and breast cancer susceptibility. Gene 2015;557:154–7
- Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012;13:1141–51
- Figueroa JD, Garcia-Closas M, Humphreys M, et al. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011;20:4693–706
- Han W, Woo JH, Yu JH, et al. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype. Cancer Epidemiol Biomarkers Prev 2011;20:793–8
- Stacey SN, Manolescu A, Sulem P, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2008;40:703–6